K. Mukanov, K. Mukantayev, and P. Tarlykov, “GPR161 RECEPTOR AS A NOVEL TARGET FOR ANTIBODY-BASED IMMUNOTHERAPY OF TRIPLE-NEGATIVE BREAST CANCER”, Eurasian Journal of Applied Biotechnology, no. 1, Jan. 2018.